(Q45998754)

English

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.

scientific article published on 8 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

1

object named as

Shyam Sundar

1 reference

Europe PubMed Central

18 December 2017

author name string

Prabat Sinha

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

T K Jha

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Jaya Chakravarty

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Madhukar Rai

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Nawin Kumar

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Krishna Pandey

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

M K Narain

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

N Verma

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

V N R Das

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

P Das

11

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Jonathan Berman

12

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Byron Arana

13

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

publication date

8 November 2012

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Tropical Medicine and International Health

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

18

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

96-100

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Post-kala-azar dermal leishmaniasis--an overview

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Miltefosine for new world cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Oral miltefosine for Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FTMI.12015

21 January 2018

Identifiers

10.1111/TMI.12015

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23136856

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45998754&oldid=1235324709"